NEW YORK (GenomeWeb) – Tempus said today that it is collaborating with the Basser Center for BRCA at the University of Pennsylvania's Abramson Cancer Center with the goal of improving and personalizing treatment for patients with heritable BRCA mutations.

Launched in 2015, Tempus is building its business around offering genomic sequencing services and proprietary analytics to clinicians and clinical research groups.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Berkeley researchers have engineered yeast to make the molecule behind the hoppy taste of beer, Quartz reports.

King's College London researchers examine the influence of school type and genetics on academic achievement.

FiveThirtyEight writes that most who take a direct-to-consumer BRCA1/2 genetic test won't learn much from it.

In Science this week: early life experience influence somatic variation in the genome, and more.